Background: Perceived stress may be a modifiable risk factor for mild cognitive impairment (MCI) and ultimately dementia, but studies on this topic from low- and middle-income countries (LMICs) are lacking. Objective: We assessed the association between perceived stress and MCI in six LMICs (China, Ghana, India, Mexico, Russia, and South Africa) using nationally representative data. Methods: Cross-sectional, community-based data on individuals aged ≥50 years from the World Health Organization’s Study on Global Ageing and Adult Health were analyzed. The definition of MCI was based on the National Institute on Ageing-Alzheimer’s Association criteria. A perceived stress score (range 0 [lowest stress] to 10 [highest stress]) was computed based on two questions from the Perceived Stress Scale. Multivariable logistic regression analysis was conducted to assess the as-sociation between perceived stress and MCI. Results: The mean (SD) age of the 32,715 participants was 62.1 (15.6) years and 51.7% were females. After adjustment for potential confounders including depression, in the overall sample, a one-unit increase in the perceived stress score was associated with a 1.14 (95% CI = 1.11–1.18) times higher odds for MCI. The association was similar among those aged 50–64 and ≥65 years. Countrywise analysis showed that there was a moderate level of between-country heterogeneity in this association (I2 = 59.4%), with the strongest association observed in Russia (OR = 1.33, 95% CI = 1.15–1.55). Conclusion: If our study results are confirmed in prospective studies, addressing perceived stress may have an impact in reducing the risk for MCI and subsequent dementia in LMICs.

Keywords:
Cognition, Perceived stress, Risk factor
1.
Wimo A, Guerchet M, Ali GC, Wu YT, Prina AM, Winblad B, Jonsson L, Liu Z, Prince M: The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement 2017; 13: 1–7.
2.
Alzheimer’s Disease International: World Alzheimer Report 2015: The Global Impact of Dementia. https://www.alz.co.uk/research/world-report-2015.
3.
Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303–308.
4.
Solfrizzi V, Panza F, Colacicco AM, D’Introno A, Capurso C, Torres F, Grigoletto F, Maggi S, Del Parigi A, Reiman EM, Caselli RJ, Scafato E, Farchi G, Capurso A: Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 2004; 63: 1882–1891.
5.
Greenberg MS, Tanev K, Marin MF, Pitman RK: Stress, PTSD, and dementia. Alzheimers Dement 2014; 10(3 suppl):S155–S165.
6.
Lazarus RS: Stress and Emotion: A New Synthesis. New York, Springer, 2006.
7.
Aggarwal NT, Wilson RS, Beck TL, Rajan KB, Mendes de Leon CF, Evans DA, Everson-Rose SA: Perceived stress and change in cognitive function among adults 65 years and older. Psychosom Med 2014; 76: 80–85.
8.
Forrester S: Perceived stress: a mechanism for cognitive decline among minorities? Am J Geriatr Psychiatry 2017; 25: 35–36.
9.
Peavy GM, Jacobson MW, Salmon DP, Gamst AC, Patterson TL, Goldman S, Mills PJ, Khandrika S, Galasko D: The influence of chronic stress on dementia-related diagnostic change in older adults. Alzheimer Dis Assoc Disord 2012; 26: 260–266.
10.
Anstey KJ: Optimizing cognitive development over the life course and preventing cognitive decline: introducing the Cognitive Health Environment Life Course Model (CHELM). Int J Behav Dev 2013; 38: 1–10.
11.
Katz MJ, Derby CA, Wang C, Sliwinski MJ, Ezzati A, Zimmerman ME, Zwerling JL, Lipton RB: Influence of perceived stress on incident amnestic mild cognitive impairment: Results from the Einstein Aging Study. Alz­heimer Dis Assoc Disord 2016; 30: 93–98.
12.
World Health Organization: Global Health and Ageing 2011. http://www.who.int/ageing/publications/global_health.pdf?ua=1.
13.
Kowal P, Chatterji S, Naidoo N, Biritwum R, Fan W, Lopez Ridaura R, Maximova T, Arokiasamy P, Phaswana-Mafuya N, Williams S, Snodgrass JJ, Minicuci N, D’Este C, Peltzer K, Boerma JT: Data resource profile: the World Health Organization Study on global AGEing and adult health (SAGE). Int J Epidemiol 2012; 41: 1639–1649.
14.
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH: The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011; 7: 270–279.
15.
Lara E, Koyanagi A, Domenech-Abella J, Miret M, Ayuso-Mateos JL, Haro JM: The impact of depression on the development of mild cognitive impairment over 3 years of follow-up: a population-based study. Dement Geriatr Cogn Disord 2017; 43: 155–169.
16.
Lara E, Koyanagi A, Olaya B, Lobo A, Miret M, Tyrovolas S, Ayuso-Mateos JL, Haro JM: Mild cognitive impairment in a Spanish representative sample: prevalence and associated factors. Int J Geriatr Psychiatry 2016; 31: 858–867.
17.
Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C: The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 1989; 39: 1159–1165.
18.
The Psychological Corporation: The WAIS III-WMS III Updated Technical Manual. San Antonio, The Psychological Corporation, 2002.
19.
Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW: Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963; 185: 914–919.
20.
Jorm AF, Jacomb PA: The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989; 19: 1015–1022.
21.
DeVylder JE, Koyanagi A, Unick J, Oh H, Nam B, Stickley A: Stress sensitivity and psychotic experiences in 39 low- and middle-income countries. Schizophr Bull 2016; 42: 1353–1362.
22.
Vancampfort D, Koyanagi A, Ward P, Veronese N, Carvalho AF, Solmi M, Mugisha J, Rosenbaum S, De Hert M, Stubbs B: Perceived stress and its relationship with chronic conditions and multimorbidity among 229,293 community-dwelling adults in 44 low- and middle-income countries. Am J Epidemiol 2017; 186: 979–989.
23.
Cohen S, Kamarck T, Mermelstein R: A global measure of perceived stress. J Health Soc Behav 1983; 24: 385–396.
24.
Amieva H, Jacqmin-Gadda H, Orgogozo JM, Le Carret N, Helmer C, Letenneur L, Barberger-Gateau P, Fabrigoule C, Dartigues JF: The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain 2005; 128: 1093–1101.
25.
Alzheimer’s Disease International: World Alzheimer Report 2014: Dementia and Risk Reduction. https://www.alz.co.uk/research/world-report-2014.
26.
Kudielka BM, Kirschbaum C: Sex differences in HPA axis responses to stress: a review. Biol Psychol 2005; 69: 113–132.
27.
Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–1558.
28.
Munoz E, Sliwinski MJ, Scott SB, Hofer S: Global perceived stress predicts cognitive change among older adults. Psychol Aging 2015; 30: 487–499.
29.
Naismith SL, Parker RM: Childhood stress and adversity is associated with late-life dementia in aboriginal Australians. Am J Geriatr Psychiatry 2017; 25: 1107–1108.
30.
Andel R, Crowe M, Hahn EA, Mortimer JA, Pedersen NL, Fratiglioni L, Johansson B, Gatz M: Work-related stress may increase the risk of vascular dementia. J Am Geriatr Soc 2012; 60: 60–67.
31.
Tschanz JT, Pfister R, Wanzek J, Corcoran C, Smith K, Tschanz BT, Steffens DC, Ostbye T, Welsh-Bohmer KA, Norton MC: Stressful life events and cognitive decline in late life: moderation by education and age. The Cache County Study. Int J Geriatr Psychiatry 2013; 28: 821–830.
32.
Pruessner JC, Dedovic K, Pruessner M, Lord C, Buss C, Collins L, Dagher A, Lupien SJ: Stress regulation in the central nervous system: evidence from structural and functional neuroimaging studies in human popula tions – 2008 Curt Richter Award Winner. Psychoneuroendocrinology 2010; 35: 179–191.
33.
Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239–259.
34.
Leonard BE: The HPA and immune axes in stress: the involvement of the serotonergic system. Eur Psychiatry 2005; 20(suppl 3): S302–S306.
35.
Kohler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, Stubbs B, Solmi M, Veronese N, Herrmann N, Raison CL, Miller BJ, Lanctot KL, Carvalho AF: Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand 2017; 135: 373–387.
36.
Lai KSP, Liu CS, Rau A, Lanctot KL, Kohler CA, Pakosh M, Carvalho AF, Herrmann N: Peripheral inflammatory markers in Alz­heimer’s disease: a systematic review and meta-analysis of 175 studies. J Neurol Neurosurg Psychiatry 2017; 88: 876–882.
37.
Tata DA, Marciano VA, Anderson BJ: Synapse loss from chronically elevated glucocorticoids: relationship to neuropil volume and cell number in hippocampal area CA3. J Comp Neurol 2006; 498: 363–374.
38.
Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM: Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer’s disease. J Neurosci 2006; 26: 9047–9056.
39.
Leon DA, Shkolnikov VM: Social stress and the Russian mortality crisis. JAMA 1998; 279: 790–791.
40.
Grossman P, Niemann L, Schmidt S, Walach H: Mindfulness-based stress reduction and health benefits. A meta-analysis. J Psychosom Res 2004; 57: 35–43.
41.
Hains A, Szyjakowski M: A cognitive stress-reduction intervention program for adolescents. J Couns Psychol 1990; 37: 79–84.
42.
Stubbs B, Vancampfort D, Rosenbaum S, Firth J, Cosco T, Veronese N, Salum GA, Schuch FB: An examination of the anxiolytic effects of exercise for people with anxiety and stress-related disorders: a meta-analysis. Psychiatry Res 2017; 249: 102–108.
43.
Iwasaki Y, Mannell RC, Smale BJ, Butcher J: Contributions of leisure participation in predicting stress coping and health among police and emergency response services workers. J Health Psychol 2005; 10: 79–99.
44.
Petersen RC: Mild cognitive impairment. Continuum (Minneap Minn) 2016; 22(2 Dementia): 404–418.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.